Table of Contents

Article

• You have access

  The evolving treatment of chronic hepatitis C: Where we stand a decade out

  Sherif Saadeh, MD and Gary L. Davis, MD

  Cleveland Clinic Journal of Medicine May 2004, 71 (5 suppl 3) S3-S7;
• You have access

  Initial treatment for chronic hepatitis C

  Keyur Patel, MD and John G. McHutchison, MD

  Cleveland Clinic Journal of Medicine May 2004, 71 (5 suppl 3) S8-S12;
• You have access

  Retreatment of patients who do not respond to initial therapy for chronic hepatitis C

  Mitchell L. Shiffman, MD

  Cleveland Clinic Journal of Medicine May 2004, 71 (5 suppl 3) S13-S16;
• You have access

  Managing the hematologic side effects of antiviral therapy for chronic hepatitis C

  Janus P. Ong, MD and Zobair M. Younossi, MD, MPH

  Cleveland Clinic Journal of Medicine May 2004, 71 (5 suppl 3) S17-S21;
• You have access

  The role of hematopoietic growth factors in special populations with chronic hepatitis C

  Stevan A. Gonzalez, MD and Ira M. Jacobson, MD

  Cleveland Clinic Journal of Medicine May 2004, 71 (5 suppl 3) S22-S26;
• You have access

  Managing the neuropsychiatric side effects of interferon-based therapy for hepatitis C

  Catherine C. Crone, MD, Geoffrey M. Gabriel, MD and Thomas N. Wise, MD

  Cleveland Clinic Journal of Medicine May 2004, 71 (5 suppl 3) S27-S32;
• You have access

  The role of physician extenders in managing patients with chronic hepatitis C

  Harpreet Gujral, RN, MSN, CRNP, Carla Viscomi, RN, BSN and Rochelle Collantes, MD, MPH

  Cleveland Clinic Journal of Medicine May 2004, 71 (5 suppl 3) S33-S37;